SUSQUEHANNA INTERNATIONAL GROUP, LLP - SIO GENE THERAPIES INC ownership

SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 52 filers reported holding SIO GENE THERAPIES INC in Q4 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of SIO GENE THERAPIES INC
ValueSharesWeighting
Q4 2022$41,493
+107.5%
95,387
+66.8%
0.00%
Q2 2022$20,000
-68.8%
57,187
-40.8%
0.00%
Q1 2022$64,000
-86.6%
96,633
-73.8%
0.00%
Q4 2021$478,000
+88.9%
369,450
+217.0%
0.00%
Q3 2021$253,000
-36.9%
116,561
-20.8%
0.00%
Q2 2021$401,000
-37.5%
147,124
-40.2%
0.00%
Q1 2021$642,000
-70.1%
245,941
-68.2%
0.00%
Q4 2020$2,146,000772,3120.00%
Other shareholders
SIO GENE THERAPIES INC shareholders Q4 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 3,186,335$8,316,0000.89%
Opaleye Management Inc. 2,000,000$5,220,0000.77%
Prosight Management, LP 205,900$537,0000.44%
Rubric Capital Management LP 2,500,418$6,526,0000.38%
Sio Capital Management, LLC 460,248$1,201,0000.24%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,489,000$14,326,0000.21%
KNOTT DAVID M 70,000$183,0000.08%
Insight Advisors, LLC/ PA 82,700$232,0000.07%
GSA CAPITAL PARTNERS LLP 146,968$384,0000.06%
Hudson Bay Capital Management LP 1,600,000$4,176,0000.05%
View complete list of SIO GENE THERAPIES INC shareholders